BRL-105

N/A

Report date: 2024/12/23 11:59:16

Base Information

Drug NameBRL-105
Drug Alias NameBRL-105
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/Indicationsalpha-ThalassemiaHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBRL Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesBRL Medicine Inc
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive Indicationsalpha-Thalassemia

Other Information

ATC CodeN/A
Related LinksN/A